In the pipeline


Number of drugs in development by New York companies


Number of biotechnology employees in New York

Includes only those companies still in existence or operating in the state in 2002

Facts and figures

New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies

For every public biotech company in New York state, there are about three private ones

The public companies within this group have a combined market capitalization of approximately $8.6 billion

Source: New York Biotechnology Assoc., "2004 State of the Industry Report"

- Francesco Fiondella

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?